skip to main content
Washington State Institute for Public Policy
Back Button

Multifactorial programs: physician-led (high-risk population)

Health Care: Falls Prevention for Older Adults
Benefit-cost methods last updated December 2023.  Literature review updated November 2017.
Open PDF
Multifactorial falls prevention programs offer more than one type of intervention, with each participant receiving a tailored combination of interventions following an initial falls risk assessment. Physician-led multifactorial interventions begin with a comprehensive medical exam in an outpatient setting which may be accompanied by some or all of the following: occupational therapy assessment; activities of daily living, home environmental, and behavioral assessment; cognition assessment; gait stability assessment; medication review, and other elements. Participants typically receive multiple clinical risk assessments after the initial comprehensive medical exam. Among included studies, the most commonly prescribed interventions following these assessments were exercise or physical therapy, occupational therapy, and medication review.

This meta-analysis includes interventions delivered to community-dwelling older adults with a high risk of falling. We classify participants as high-risk if they were selected for falls risk factors or if they were recruited from an inpatient setting.
 
ALL
BENEFIT-COST
META-ANALYSIS
CITATIONS
For an overview of WSIPP's Benefit-Cost Model, please see this guide. The estimates shown are present value, life cycle benefits and costs. All dollars are expressed in the base year chosen for this analysis (2022). The chance the benefits exceed the costs are derived from a Monte Carlo risk analysis. The details on this, as well as the economic discount rates and other relevant parameters are described in our Technical Documentation.
Benefit-Cost Summary Statistics Per Participant
Benefits to:
Taxpayers $557 Benefits minus costs $412
Participants $70 Benefit to cost ratio $1.23
Others $87 Chance the program will produce
Indirect $1,476 benefits greater than the costs 63%
Total benefits $2,191
Net program cost ($1,779)
Benefits minus cost $412

^WSIPP’s benefit-cost model does not monetize this outcome.

^^WSIPP does not include this outcome when conducting benefit-cost analysis for this program.

‡The effect size for this outcome indicates an incidence rate ratio (IRR), not a standardized mean difference effect size. An IRR less than one indicates a lower rate of the outcome in the treatment group relative to the comparison group; an IRR greater than one indicates a higher rate of the outcome. The treatment n for this outcome represents person-years.

Meta-analysis is a statistical method to combine the results from separate studies on a program, policy, or topic in order to estimate its effect on an outcome. WSIPP systematically evaluates all credible evaluations we can locate on each topic. The outcomes measured are the types of program impacts that were measured in the research literature (for example, crime or educational attainment). Treatment N represents the total number of individuals or units in the treatment group across the included studies.

An effect size (ES) is a standard metric that summarizes the degree to which a program or policy affects a measured outcome. If the effect size is positive, the outcome increases. If the effect size is negative, the outcome decreases. See Estimating Program Effects Using Effect Sizes for additional information.

Adjusted effect sizes are used to calculate the benefits from our benefit cost model. WSIPP may adjust effect sizes based on methodological characteristics of the study. For example, we may adjust effect sizes when a study has a weak research design or when the program developer is involved in the research. The magnitude of these adjustments varies depending on the topic area.

WSIPP may also adjust the second ES measurement. Research shows the magnitude of some effect sizes decrease over time. For those effect sizes, we estimate outcome-based adjustments which we apply between the first time ES is estimated and the second time ES is estimated. We also report the unadjusted effect size to show the effect sizes before any adjustments have been made. More details about these adjustments can be found in our Technical Documentation.

Meta-Analysis of Program Effects
Outcomes measured Treatment age No. of effect sizes Treatment N Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis Unadjusted effect size (random effects model)
First time ES is estimated Second time ES is estimated
ES SE Age ES SE Age ES p-value
Falls‡
An event which results in a person coming to rest inadvertently on the ground or floor or other lower level.
 79 2 278 0.675 0.047 79 1.000 0.000 80 0.675 0.001
Emergency department visits^^
Whether someone visited the emergency department, or the number of times they visited the emergency department.
79 1 159 -0.079 0.184 79 n/a n/a n/a -0.079 0.668
Fall-related hospitalization^
Hospitalization as a result of a fall.
 79 2 369 0.030 0.092 79 n/a n/a n/a 0.030 0.741
1In addition to the outcomes measured in the meta-analysis table, WSIPP measures benefits and costs estimated from other outcomes associated with those reported in the evaluation literature. For example, empirical research demonstrates that high school graduation leads to reduced crime. These associated measures provide a more complete picture of the detailed costs and benefits of the program.

2“Others” includes benefits to people other than taxpayers and participants. Depending on the program, it could include reductions in crime victimization, the economic benefits from a more educated workforce, and the benefits from employer-paid health insurance.

3“Indirect benefits” includes estimates of the net changes in the value of a statistical life and net changes in the deadweight costs of taxation.
Detailed Monetary Benefit Estimates Per Participant
Affected outcome: Resulting benefits:1 Benefits accrue to:
Taxpayers Participants Others2 Indirect3 Total
Falls Health care associated with falls $557 $70 $87 $279 $993
Mortality associated with falls $0 $0 $0 $2,087 $2,087
Program cost Adjustment for deadweight cost of program $0 $0 $0 ($889) ($889)
Totals $557 $70 $87 $1,476 $2,191
Click here to see populations selected
Detailed Annual Cost Estimates Per Participant
Annual cost Year dollars Summary
Program costs $1,508 2016 Present value of net program costs (in 2022 dollars) ($1,779)
Comparison costs $0 2016 Cost range (+ or -) 70%
Per-participant cost estimates are based on a weighted average of the costs in the included studies. We use a cost study on multifactorial falls prevention programs (Day, L., Hoareau, E., Finch, C., Harrison, J., Segal, L., Bolton, T., & Ullah, S. (2009). Modelling the impact, costs and benefits of falls prevention measures to support policy-makers and program planners. Monash University Accident Research Centre) to inform our assumptions around resource use; apply 2016 mean hourly wages for relevant providers in Washington from the U.S. Bureau of Labor Statistics (retrieved March 2018); and increase wages by a factor of 1.441 to account for the cost of employee benefits. Based on the work of Day et al., 2009, we estimate the cost of services including initial assessments, a team meeting, administrative assistance, and a geriatric review. We assume the initial physician assessment lasted 40 minutes; initial assessments by a nurse, physical therapist, and occupational therapist lasted 27 minutes each; and administrative assistance by a medical secretary lasted 30 minutes. For each intervention that delivered treatment based on assessment results, we include an average per-participant cost for such treatment, based on the components reported by Day et al., 2009. To convert the healthcare costs reported in Day et al., 2009 (in Australian dollars), we compute a conversion factor by comparing compensation rates reported in that study with those in Washington State. To convert non-healthcare costs reported in Day et al., 2009, we compute a conversion factor using Campbell and Cochrane Economics Methods Group & the Evidence for Policy and Practice Information and Coordinating Centre. (n.d.). CCEMG – EPPI-Centre Cost Converter (v.1.5). Retrieved 3/16/2018, from https://eppi.ioe.ac.uk/costconversion/.
The figures shown are estimates of the costs to implement programs in Washington. The comparison group costs reflect either no treatment or treatment as usual, depending on how effect sizes were calculated in the meta-analysis. The cost range reported above reflects potential variation or uncertainty in the cost estimate; more detail can be found in our Technical Documentation.
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
Benefits Minus Costs Over Time (Cumulative Discounted Dollars)
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.

Citations Used in the Meta-Analysis

Conroy, S., Kendrick, D., Harwood, R., Gladman, J., Coupland, C., Sach, T., . . . Masud, T. (2010). A multicentre randomised controlled trial of day hospital-based falls prevention programme for a screened population of community-dwelling older people at high risk of falls. Age and Ageing, 39(6), 704-710.

Davison, J., Bond, J., Dawson, P., Steen, I.N., & Kenny, R.A. (2005). Patients with recurrent falls attending Accident & Emergency benefit from multifactorial intervention—a randomised controlled trial. Age and Ageing, 34(2), 162-8.

Spice, C.L., Morotti, W., George, S., Dent, T.H., Rose, J., Harris, S., & Gordon, C.J. (2009). The Winchester Falls Project: A randomised controlled trial of secondary prevention of falls in older people. (Age and Ageing, 38( (1), 33-40.